TransGen Biotech
 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
TransGen Biotech, Inc. is a researcher, developer, manufacturer and distributor of more than 200 molecular and cellular biology products and kits for life science research and molecular diagnostics. In 2001, the company was founded by three scientists with a mission to produce innovative and cost-effective products for life science research. Currently, their products cover: plasmid based DNA markers, high efficiency chemically competent cells, 5 minutes PCR product cloning and expression vectors, a variety of PCR enzymes and supermix, RNase H deficient and high temperature RT enzymes, qPCR and qRT-PCR supermix, the highest efficiency mutagenesis kits, high quality nucleic acid extraction and purification kits, unstained and prestained protein markers, western blot markers, and protein purification resins, cell culture and transfection reagents, antibodies.
Read more :
Watch the videos:
Website : www.transgenbiotech.com
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Recombinase expression plasmids
Recombinase expression plasmids are powerful tools in the field of molecular biology, offering researchers the ability to manipulate and edit genetic material with precision and efficiency. Recombinases are enzymes that are capable of recognizing specific DNA sequences and catalyzing the exchange of DNA segments between these sequences, allowing for the precise manipulation of genetic material.
In recent years, the development of recombinase expression plasmids has revolutionized the field of genetic engineering, enabling the creation of genetically modified organisms with unprecedented precision and control. These plasmids allow for the expression of recombinases in cells, allowing researchers to target specific genetic sequences for manipulation.
The development of recombinase expression plasmids has not only advanced the field of genetic engineering, but has also created new opportunities for marketing and commercialization of genetic engineering technologies. Companies are now offering recombinase expression plasmids as research tools to the scientific community, with the aim of advancing the understanding of genetics and the development of new therapeutics.